The Emerging Pathogen Candida metapsilosis: Biological Aspects, Virulence Factors, Diagnosis, and Treatment
Manuela Gómez-Gaviria,Laura García-Carnero,Dario Baruch-Martínez,Héctor Mora-Montes
DOI: https://doi.org/10.2147/idr.s448213
2024-01-20
Infection and Drug Resistance
Abstract:Manuela Gómez-Gaviria, Laura C García-Carnero, Dario A Baruch-Martínez, Héctor M Mora-Montes Departamento de Biología, División de Ciencias Naturales y Exactas, Universidad de Guanajuato, Guanajuato, Gto., México Correspondence: Héctor M Mora-Montes, Departamento de Biología, División de Ciencias Naturales y Exactas, Campus Guanajuato, Universidad de Guanajuato, Noria Alta s/n, col. Noria Alta, C.P. 36050, Guanajuato, Gto., México, Tel +52 473-7320006 Ext. 8193, Fax +52 473-7320006 Ext. 8153, Email Fungal infections represent a constant and growing menace to public health. This concern is due to the emergence of new fungal species and the increase in antifungal drug resistance. Mycoses caused by Candida species are among the most common nosocomial infections and are associated with high mortality rates when the infection affects deep-seated organs. Candida metapsilosis is part of the Candida parapsilosis complex and has been described as part of the oral microbiota of healthy individuals. Within the complex, this species is considered the least virulent; however, the prevalence has been increasing in recent years, as well as an increment in the resistance to some antifungal drugs. One of the main concerns of candidiasis caused by this species is the wide range of clinical manifestations, ranging from tissue colonization to superficial infections, and in more severe cases it can spread, which makes diagnosis and treatment difficult. The study of virulence factors of this species is limited, however, proteomic comparisons between species indicate that virulence factors in this species could be similar to those already described for C. albicans . However, differences may exist, taking into account changes in the lifestyle of the species. Here, we provide a detailed review of the current literature about this organism, the caused disease, and some sharing aspects with other members of the complex, focusing on its biology, virulence factors, the host-fungus interaction, the identification, diagnosis, and treatment of infection. Keywords: antifungal resistance, candidiasis, Candida parapsilosis complex, emerging pathogens, virulence factors The Candida genus groups fungal species of yeast-like organisms, and from the approximately 200 species belonging to it, only 17 species are the most frequently isolated from clinical specimens. 1 Collectively, these species are the etiological agents of candidiasis, a medically relevant fungal infection that can affect superficial or deep-seated organs. Candida albicans is the most common organism that causes candidiasis in humans and thus is the species whose pathogenesis, virulence, epidemiology, and susceptibility to antifungal drugs have been thoroughly studied. However, nowadays the emergence of new species in the clinical setting is widely recognized and other Candida species, such as Candida parapsilosis, Candida orthopsilosis, Candida metapsilosis, Candida krusei, Candida lusitaniae, Candida glabrata , and Candida tropicalis , have recently attracted attention. 1–6 Candidiasis, colloquially known as thrush, shows a wide range of infections throughout the body and is responsible for about 96% of all mycoses in immunocompromised patients. 7,8 With no doubt, the highest mortality toll is associated with candidemia, 1,4,6 which implies the fungal dispersion to different organs by the bloodstream. On the contrary, superficial candidiasis is often an infection of mucosal (buccal, vulvovaginal, esophageal) or cutaneous (skin and nails) tissues, with benign or mild symptoms that can affect both immunocompetent and immunocompromised patients. 9 It is estimated that up to 75% of women suffer from vulvovaginal candidiasis caused by Candida spp. at least once in their life. 10 C. parapsilosis sensu lato is the second most found Candida isolate in bloodstream samples from Latin America and Asia, and the third overall Candida species isolated worldwide. 11 From those isolates, it has been reported that around 90% were identified as Candida parapsilosis sensu stricto ; while the rest as C. orthopsilosis and C. metapsilosis . 12 C. metapsilosis is ubiquitous and has been reported as part of the oral mycobiome of healthy individuals. 13,14 This species is reported as the least common and virulent species of the complex, given that just around 1.1 to 8.4% of the infections caused by C. parapsilosis sensu lato are attributed to C. metapsilosis . 15,16 Even though it is considered the least important species of the complex, its prevalence has increased over the years and has also been linked to challenging cli -Abstract Truncated-
pharmacology & pharmacy,infectious diseases